Product NDC: | 0095-7029 |
Proprietary Name: | Orbivan |
Non Proprietary Name: | Acetaminophen, butalbital and caffeine |
Active Ingredient(s): | 300; 50; 40 mg/1; mg/1; mg/1 & nbsp; Acetaminophen, butalbital and caffeine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0095-7029 |
Labeler Name: | ECR Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040885 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120821 |
Package NDC: | 0095-7029-05 |
Package Description: | 500 CAPSULE in 1 BOTTLE (0095-7029-05) |
NDC Code | 0095-7029-05 |
Proprietary Name | Orbivan |
Package Description | 500 CAPSULE in 1 BOTTLE (0095-7029-05) |
Product NDC | 0095-7029 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Acetaminophen, butalbital and caffeine |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120821 |
Marketing Category Name | ANDA |
Labeler Name | ECR Pharmaceuticals |
Substance Name | ACETAMINOPHEN; BUTALBITAL; CAFFEINE |
Strength Number | 300; 50; 40 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes | Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |